Articles by James Calloway
JetBlue Rides Fare Hikes to 6% Gain Despite Fuel Surge and Debt Concerns
JetBlue (JBLU) shares climbed 6.2% as higher fares helped offset a sharp rise in fuel costs, though the airline's net loss widened to $247 million and its heavy debt load remains a concern.
First Solar Shares Surge 3.4% on Q2 Earnings Beat, Boosted by Tariff Refund
First Solar (FSLR) shares surged 3.4% after Q2 earnings of $3.92 per share topped the $2.99 consensus, with a $88.6 million tariff refund lifting gross margin to 57.3%. Revenue matched forecasts at $1.06 billion.
Reddit stock dips 9% after-hours despite Q2 earnings beat as US user growth stalls
Reddit shares dropped 9.3% in after-hours trading despite a Q2 earnings beat, as U.S. daily active users flattened and revenue growth is expected to slow in Q3.
Rivian Stock Rises on Q2 Beat, But Software Props Up Profit
Rivian shares climbed after Q2 results exceeded expectations, but gross profit was entirely driven by software, masking an automotive segment loss.
Roblox Shares Tumble 12% as Weak Q3 Bookings Forecast Dampens Cash Flow Optimism
Roblox shares dropped 12% in after-hours trading after issuing a disappointing Q3 bookings forecast, overshadowing better-than-expected Q2 revenue and cash flow.
Ford Stock Retreats After CEO Warns of Chinese EV Threat to US Market
Ford shares gave up post-earnings gains after CEO Jim Farley warned Chinese automakers could enter the US market within 5-10 years. Q2 adjusted EPS beat estimates at $0.42, but Model e losses remain substantial.
Ambev ADRs Recover from Steep Drop as Cash Flow Surge Fuels Optimism
Ambev ADRs recovered sharply after a 5.5% intraday slide, as Q2 operating cash flow jumped 54.5%, though 79% of the rise came from working capital.
UiPath Stock Slides on Weak ARR Growth Forecast for Q2
UiPath stock dropped 3.3% after the company projected Q2 net new ARR between $28M and $33M, a 38% decline from Q1, signaling decelerating growth.
Corcept Shares Leap 27% on Strong Lifyorli Launch and Upbeat Guidance
Corcept Therapeutics shares jumped 27.4% after Q2 revenue rose 32% to $256.1M, driven by Lifyorli sales of $47.6M. The company lifted its 2026 revenue outlook to $1.1-1.2 billion.
Chipotle Shares Surge 13% on Strong Q2 Sales, Margins Under Pressure
Chipotle shares surged 13% after Q2 comparable sales rose 2.2%, topping forecasts. Margins tightened as costs ate up nearly all incremental revenue, but a raised outlook and share repurchases supported the stock.
